|
Report Date : |
27.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
YEN CHEN MACHINERY CO., LTD. |
|
|
|
|
Registered Office : |
No.38, Huaya 1st Rd., Gueishan Township, Taoyuan County 333 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
14.09.1970 |
|
|
|
|
Com. Reg. No.: |
29531512 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
line of business
: |
Manufacture and sales of pharmaceutical equipments, etc |
|
|
|
|
No. of Employees : |
About 100 employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
No.38, Huaya 1st
Rd., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.) |
|
Supplied Address: |
|
|
Telephone Number: |
+886-3-328-9396 |
|
Fax Number: |
|
|
E-mail: |
Notes: Subject’s exact name and address are as
above and the supplied name also belongs to subject.
Subject was incorporated on
|
Name |
Subscription Shares |
|
Qingsan Liu |
1,211,277 |
|
Wensheng Zheng |
|
|
414,667 |
|
|
Qiongying Liu |
2,051,900 |
|
Chengquan Wu |
475,408 |
The information above is that of subject’s major shareholders.
Kunshan Branch
|
Address |
South Side, Qingsong Road, Yushan Town, Kunshan City, Jiangsu
Province, China |
|
Tel |
+86-512-8616-1366 |
|
Fax: |
+86-512-8616-1355 |
Core Management
Directors
|
1 |
|
|
Name |
Qingsan Liu |
|
Position |
Board Chairman & Manager |
|
Date of Appointment |
|
|
2 |
|
|
Name |
Wensheng Zheng |
|
Position |
Director & Manager |
|
Date of Appointment |
|
|
3 |
|
|
Name |
Qiongying Liu |
|
Position |
Director & Manager |
|
Date of Appointment |
|
|
4 |
|
|
Name |
Chengquan Wu |
|
Position |
Supervisor |
|
5 |
|
|
Name |
Yihua Liu |
|
Position |
Manager |
|
Date of Appointment |
|
|
6 |
|
|
Name |
Shihao Xu |
|
Position |
Manager |
|
Date of Appointment |
|
|
7 |
|
|
Name |
Litu Shi |
|
Position |
Manager |
|
Date of Appointment |
|
|
8 |
|
|
Name |
Qingyao Su |
|
Position |
Manager |
|
Date of Appointment |
|
Personnel Structure
|
Total Employees |
About 100 employees |
Offices & Factories
|
|
Headquarters |
|
Add |
No.38, Huaya 1st Rd., Gueishan Township, Taoyuan County 333, Taiwan
(R.O.C.) |
Production Information
Subject is engaged in manufacture of pharmaceutical machines.
It is introduced that subject has been certificated by ISO 9001 and ISO
9002
Purchase Information
The registered activities of subject:
|
1 |
Design, manufacture, sales and maintenance
of all kinds of machines and components |
|
2 |
Manufacture, sales and maintenance
of instruments |
|
3 |
Design, contract, maintenance and sales for all kinds of
mechanical engineering, Automotive Engineering, Environmental Engineering and
surveying engineering, etc |
|
3 |
Marketing, price quoting and bidding service of the above mentioned products
for domestic and overseas customers |
|
4 |
Import and export business of the above mentioned products |
Subject purchases raw materials and components both at home and abroad.
The subject is mainly engaged in pharmaceutical
machines including Extraction & Pellet & Coating & Pharmaceutical
machine, High Shear Mixer, and Fluid Bed Dryer, etc
Subject’s products are applied to pharmaceutical industry, food industry
and biotechnology industry, etc
Subject’s products are both sold in domestic and overseas market and its
sales regions spreads over 50 countries such as: Europe, America, Japan, South
Korea, Russia, Australia, Africa, Middle East, South Asia, and South East Asia
Subject’s major customers include Wyeth, Novartis, Abbott, Boehringer
Ingelheim, GSK, Merck, Eli Lilly, Sankyo, Takeda, Eisai, Otsuka, YSP, Novast,
Sanofi-Aventis, etc.
Import and export right:
|
Import right |
Yes |
|
Export right |
Yes |
Domestic Purchase
|
Payment Terms |
Proportion |
|
|
Raw materials,
etc |
COD, Credit
Sales, etc |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
Raw materials,
etc |
CBD, etc |
100% |
Sales
Domestic Markets
|
Sales Terms |
Proportion |
|
|
Pharmaceutical
Equipments, etc |
CBD, etc |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Pharmaceutical
Equipments, etc |
CBD, etc |
100% |
Subject has no obligations to disclose its financial
statements to the third party according to the relevant policy in Taiwan and
the only source from which we can obtain the information is the subject itself.
Subject declined to disclose its financials
citing the grounds of company’s confidentiality; from other source we can not
obtain the relevant information, either.
Subject declined to disclose its bank details;
from other source we can not obtain the relevant information, either.
Mortgage
No chattel mortgage record of subject has been
found within the recent 3 months.
Lawsuit
Up to date of reporting, no existing or latent
litigation of the subject has been found.
|
Department |
Sales department |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.38 |
|
UK Pound |
1 |
Rs.87.80 |
|
Euro |
1 |
Rs.69.48 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.